Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03005717 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat
A Phase 2 study of Submental Fat, sponsored by Neothetics.
- Completed
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
- 11
- Study locations
NCT03005717 is a Phase 2 study of Submental Fat that has completed, run by Neothetics. The registered enrollment target is 162 participants. The trial reports 11 study locations across 10 states.
The verdict
NCT03005717, a Phase 2 study of Submental Fat, has completed, sponsored by Neothetics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
- 11
- Study locations
Study Summary
Study LIPO-202-CL-31 is a multi center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of LIPO-202 versus placebo on submental bulging due to subcutaneous fat. Approximately 150 participants of either gender who have a "Moderate Bulge" or "Large Bulge" in the submental fat (on Patient-Reported Submental Bulging Scale \[PR-SBS\] and Clinician-Reported Submental Bulging Scale \[CR-SBS\]) will be recruited for this study.
Conditions Studied
Interventions
- DRUG LIPO-202
- DRUG Placebo for LIPO-202
Study Locations (11)
California
- Clinical Testing of Beverly Hills - Beverly Hills
- Ablon Skin Institute And Research Center - Manhattan Beach
Colorado
- AboutSkin Research - Greenwood Village
Florida
- Skin Research Institute - Coral Gables
Michigan
- Grekin Skin Institute - Warren
Minnesota
- Minnesota Clinical Study Center - Fridley
Missouri
- Mercy Research - Washington
Nebraska
- Skin Specialists, PC - Omaha
New York
- Juva Skin & Laser Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2016-12-22 |
| Est. Completion | 2017-06-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03005717
The ClinicalTrials.gov registry entry for NCT03005717 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neothetics, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Submental Fat appearing as the primary indexed condition, and to 2 interventions - of which LIPO-202 is the first listed.
NCT03005717 reports 11 study locations spanning 10 distinct geographic areas - top geographies include California, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT03005717 about?
NCT03005717 is a clinical study titled "Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat". Study LIPO-202-CL-31 is a multi center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of LIPO-202 versus placebo on submental bulging due to subcutaneous fat. Approximately 150 participants of either gender who have a "Moderate Bulge" o...
What is the current status of trial NCT03005717?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2016-12-22. Estimated completion is 2017-06-02.
What conditions does trial NCT03005717 study?
This clinical trial studies the following conditions: Submental Fat.
What interventions are being tested in trial NCT03005717?
The interventions under investigation include: LIPO-202 (DRUG), Placebo for LIPO-202 (DRUG).
Who is sponsoring clinical trial NCT03005717?
This trial is sponsored by Neothetics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03005717 being conducted?
This trial has 11 study locations across California, Colorado, Florida, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Submental Fat
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.